{"pending_diagnosis": "This case demonstrates a classic, devastating presentation of a life-threatening acute metabolic crisis, often misdiagnosed as purely psychiatric or neurological until it's too late.\n\n<b>DIAGNOSIS:</b>\n<span class=\"tg-spoiler\">Acute Intermittent Porphyria (AIP)</span>\n\n<b>THE SMOKING GUN:</b>\n<span class=\"tg-spoiler\">The combination of severe, unexplained abdominal pain, profound acute polyneuropathy, psychiatric symptoms (hallucinations/agitation), autonomic instability (tachycardia/hypertension), and the trigger (Sulfonamide antibiotic), confirmed by the urine darkening upon standing.</span>\n\n<b>PATHOPHYSIOLOGY:</b>\nAcute Intermittent Porphyria is an autosomal dominant disorder caused by a partial deficiency of the enzyme Porphobilinogen Deaminase (PBGD), also known as Hydroxymethylbilane Synthase. This enzyme deficiency causes a bottleneck in the heme synthesis pathway. When triggered by certain drugs (like sulfonamides, barbiturates, or alcohol), starvation, or hormonal changes, the upstream intermediates\u2014specifically Porphobilinogen (PBG) and Delta-Aminolevulinic Acid (ALA)\u2014accumulate in massive quantities. These precursors are neurotoxic.\n\nThe clinical manifestations stem entirely from this neurotoxicity:\n1.  Abdominal pain: Due to visceral autonomic neuropathy/spasm.\n2.  Hypertension/Tachycardia: Due to sympathetic overactivity.\n3.  Peripheral Neuropathy (flaccid paralysis): Due to axonal damage.\n4.  Psychiatric Symptoms: Direct toxicity on the CNS.\n\nConfirmation requires testing for elevated urinary ALA and PBG, which will be profoundly high during an acute attack. Treatment involves withdrawal of the offending agent, high-dose glucose infusion, and, crucially, intravenous hematin (Heme Arginitate) to suppress ALA synthase activity and thus slow the production of the toxic intermediates."}